Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9963
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mitkovski, Sascha | - |
dc.contributor.author | Villemagne, Victor L | - |
dc.contributor.author | Novakovic, Kathy E | - |
dc.contributor.author | O'Keefe, Graeme J | - |
dc.contributor.author | Tochon-Danguy, Henri | - |
dc.contributor.author | Mulligan, Rachel S | - |
dc.contributor.author | Dickinson, Kerryn L | - |
dc.contributor.author | Saunder, Tim | - |
dc.contributor.author | Gregoire, Marie-Claude | - |
dc.contributor.author | Bottlaender, Michel | - |
dc.contributor.author | Dolle, Frederic | - |
dc.contributor.author | Rowe, Christopher C | - |
dc.date.accessioned | 2015-05-15T23:15:40Z | |
dc.date.available | 2015-05-15T23:15:40Z | |
dc.date.issued | 2005-08-01 | - |
dc.identifier.citation | Nuclear Medicine and Biology; 32(6): 585-91 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/9963 | en |
dc.description.abstract | Neuronal nicotinic acetylcholine receptors (nAChRs), widely distributed in the human brain, are implicated in various neurophysiological processes as well as being particularly affected in neurodegenerative conditions such as Alzheimer's disease. We sought to evaluate a minimally invasive method for quantification of nAChR distribution in the normal human brain, suitable for routine clinical application, using 2[(18)F]F-A-85380 and positron emission tomography (PET).Ten normal volunteers (four females and six males, aged 63.40+/-9.22 years) underwent a dynamic 120-min PET scan after injection of 226 MBq 2[(18)F]F-A-85380 along with arterial blood sampling. Regional binding was assessed through standardized uptake value (SUV) and distribution volumes (DV) obtained using both compartmental (DV(2CM)) and graphical analysis (DV(Logan)). A simplified approach to the estimation of DV (DV(simplified)), defined as the region-to-plasma ratio at apparent steady state (90-120 min post injection), was compared with the other quantification approaches.DV(Logan) values were higher than DV(2CM). A strong correlation was observed between DV(simplified), DV(Logan) (r=.94) and DV(2CM) (r=.90) in cortical regions, with lower correlations in thalamus (r=.71 and .82, respectively). Standardized uptake value showed low correlation against DV(Logan) and DV(2CM).DV(simplified) determined by the ratio of tissue to metabolite-corrected plasma using a single 90- to 120-min PET acquisition appears acceptable for quantification of cortical nAChR binding with 2[(18)F]F-A-85380 and suitable for clinical application. | en |
dc.language.iso | en | en |
dc.subject.other | Azetidines.diagnostic use.pharmacokinetics | en |
dc.subject.other | Blood Specimen Collection | en |
dc.subject.other | Brain.metabolism.radionuclide imaging | en |
dc.subject.other | Brain Mapping | en |
dc.subject.other | Female | en |
dc.subject.other | Fluorine Radioisotopes.diagnostic use.pharmacokinetics | en |
dc.subject.other | Humans | en |
dc.subject.other | Image Interpretation, Computer-Assisted | en |
dc.subject.other | Kinetics | en |
dc.subject.other | Male | en |
dc.subject.other | Metabolic Clearance Rate | en |
dc.subject.other | Middle Aged | en |
dc.subject.other | Positron-Emission Tomography.methods | en |
dc.subject.other | Pyridines.diagnostic use.pharmacokinetics | en |
dc.subject.other | Radiopharmaceuticals.diagnostic use.pharmacokinetics | en |
dc.subject.other | Receptors, Nicotinic.metabolism | en |
dc.subject.other | Tissue Distribution | en |
dc.title | Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Nuclear medicine and biology | en |
dc.identifier.affiliation | Department of Nuclear Medicine and Centre for PET, Austin Hospital, Victoria 3084, Melbourne, Australia | en |
dc.identifier.doi | 10.1016/j.nucmedbio.2005.04.013 | en |
dc.description.pages | 585-91 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/16026705 | en |
dc.type.content | Text | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Mulligan, Rachel S | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.